Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus.

Burgess HM, Pourchet A, Hajdu CH, Chiriboga L, Frey AB, Mohr I.

Mol Ther Oncolytics. 2018 Jan 31;8:71-81. doi: 10.1016/j.omto.2018.01.001. eCollection 2018 Mar 30.

2.

Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer.

Jang JE, Hajdu CH, Liot C, Miller G, Dustin ML, Bar-Sagi D.

Cell Rep. 2017 Jul 18;20(3):558-571. doi: 10.1016/j.celrep.2017.06.062.

3.

Paget's disease of the anus masking a mixed adenoneuroendocrine tumour of the rectum.

Ebrom P, Parizh D, Hajdu CH, Gadangi P.

BMJ Case Rep. 2017 Feb 14;2017. pii: bcr2016218717. doi: 10.1136/bcr-2016-218717.

4.

Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).

Hoffman DH, Ream JM, Hajdu CH, Rosenkrantz AB.

Abdom Radiol (NY). 2017 Apr;42(4):1222-1228. doi: 10.1007/s00261-016-1001-7.

PMID:
27900458
5.

Direct acting antiviral therapy is curative for chronic hepatitis C/autoimmune hepatitis overlap syndrome.

Sahebjam F, Hajdu CH, Nortey E, Sigal SH.

World J Hepatol. 2016 May 18;8(14):632-6. doi: 10.4254/wjh.v8.i14.632.

6.

Comparison of MRI features of pathologically proven hepatocellular carcinoma between patients with hepatitis B and hepatitis C infection.

Dunst D, Ream JM, Khalef V, Hajdu CH, Rosenkrantz AB.

Clin Imaging. 2016 May-Jun;40(3):352-6. doi: 10.1016/j.clinimag.2016.01.014. Epub 2016 Jan 28.

PMID:
27133666
7.

IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia.

Pylayeva-Gupta Y, Das S, Handler JS, Hajdu CH, Coffre M, Koralov SB, Bar-Sagi D.

Cancer Discov. 2016 Mar;6(3):247-55. doi: 10.1158/2159-8290.CD-15-0843. Epub 2015 Dec 29.

8.

Utility of diffusion-weighted MRI for differentiating acute from chronic cholecystitis.

Wang A, Shanbhogue AK, Dunst D, Hajdu CH, Rosenkrantz AB.

J Magn Reson Imaging. 2016 Jul;44(1):89-97. doi: 10.1002/jmri.25128. Epub 2015 Dec 22.

PMID:
26691912
9.

Solitary fibrous tumor of the pancreas.

Baxter AR, Newman E, Hajdu CH.

J Surg Case Rep. 2015 Dec 1;2015(12). pii: rjv144. doi: 10.1093/jscr/rjv144.

10.

Differentiation of Malignant Omental Caking from Benign Omental Thickening using MRI.

Doshi AM, Campbell N, Hajdu CH, Rosenkrantz AB.

Abdom Imaging. 2015 Jun;40(5):1157-63. doi: 10.1007/s00261-014-0259-x.

PMID:
25311992
11.

A rare cause of noncirrhotic intrahepatic portal hypertension.

Chugh P, Park JS, Hajdu CH.

Gastroenterology. 2014 Sep;147(3):e7-9. doi: 10.1053/j.gastro.2014.04.004. Epub 2014 Jul 23. No abstract available.

PMID:
25064548
12.

Comparison of MRI pulse sequences for prediction of size of hepatocellular carcinoma at explant evaluation.

Seuss CR, Kim MJ, Triolo MJ, Hajdu CH, Rosenkrantz AB.

AJR Am J Roentgenol. 2014 Aug;203(2):300-5. doi: 10.2214/AJR.13.11688.

PMID:
25055263
13.

Optimizing needle direction during transjugular liver biopsy provides superior biopsy specimens.

Clark TW, McCann JW, Salsamendi J, Dowd MF, Hajdu CH.

Cardiovasc Intervent Radiol. 2014 Dec;37(6):1540-5. doi: 10.1007/s00270-013-0819-4. Epub 2013 Dec 19.

PMID:
24352863
14.

Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI.

Taouli B, Johnson RS, Hajdu CH, Oei MT, Merad M, Yee H, Rusinek H.

AJR Am J Roentgenol. 2013 Oct;201(4):795-800. doi: 10.2214/AJR.12.9798.

15.

Comparison of CT and MRI findings in the differentiation of acute from chronic cholecystitis.

Kaura SH, Haghighi M, Matza BW, Hajdu CH, Rosenkrantz AB.

Clin Imaging. 2013 Jul-Aug;37(4):687-91. doi: 10.1016/j.clinimag.2013.02.009. Epub 2013 Mar 28.

PMID:
23541278
16.

Primary rhabdomyosarcoma of the diaphragm: case report and review of the literature.

Melis M, Rosen G, Hajdu CH, Pachter HL, Raccuia JS.

J Gastrointest Surg. 2013 Apr;17(4):799-804. doi: 10.1007/s11605-013-2158-9. Epub 2013 Feb 9. Review.

PMID:
23397333
17.

Pancreatic cancer: lack of association between apparent diffusion coefficient values and adverse pathological features.

Rosenkrantz AB, Matza BW, Sabach A, Hajdu CH, Hindman N.

Clin Radiol. 2013 Apr;68(4):e191-7. doi: 10.1016/j.crad.2012.11.006. Epub 2013 Jan 11.

PMID:
23312674
18.

Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.

Mannelli L, Kim S, Hajdu CH, Babb JS, Taouli B.

Eur J Radiol. 2013 Apr;82(4):577-82. doi: 10.1016/j.ejrad.2012.11.026. Epub 2012 Dec 14.

PMID:
23246330
19.

The effect of liver iron deposition on hepatic apparent diffusion coefficient values in cirrhosis.

Chandarana H, Do RK, Mussi TC, Jensen JH, Hajdu CH, Babb JS, Taouli B.

AJR Am J Roentgenol. 2012 Oct;199(4):803-8.

PMID:
22997371
20.

MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells.

Ochi A, Nguyen AH, Bedrosian AS, Mushlin HM, Zarbakhsh S, Barilla R, Zambirinis CP, Fallon NC, Rehman A, Pylayeva-Gupta Y, Badar S, Hajdu CH, Frey AB, Bar-Sagi D, Miller G.

J Exp Med. 2012 Aug 27;209(9):1671-87. doi: 10.1084/jem.20111706. Epub 2012 Aug 20.

21.

Assessment of hepatocellular carcinoma using apparent diffusion coefficient and diffusion kurtosis indices: preliminary experience in fresh liver explants.

Rosenkrantz AB, Sigmund EE, Winnick A, Niver BE, Spieler B, Morgan GR, Hajdu CH.

Magn Reson Imaging. 2012 Dec;30(10):1534-40. doi: 10.1016/j.mri.2012.04.020. Epub 2012 Jul 20.

PMID:
22819175
22.

Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia.

Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D.

Cancer Cell. 2012 Jun 12;21(6):836-47. doi: 10.1016/j.ccr.2012.04.024.

23.

Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients.

Park MS, Kim S, Patel J, Hajdu CH, Do RK, Mannelli L, Babb JS, Taouli B.

Hepatology. 2012 Jul;56(1):140-8. doi: 10.1002/hep.25681. Epub 2012 Jun 18.

PMID:
22370974
24.

Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation.

Krishnan P, Fiel MI, Rosenkrantz AB, Hajdu CH, Schiano TD, Oyfe I, Taouli B.

AJR Am J Roentgenol. 2012 Feb;198(2):370-6. doi: 10.2214/AJR.11.6855.

PMID:
22268180
25.

Well-differentiated pancreatic neuroendocrine carcinoma in tuberous sclerosis--case report and review of the literature.

Arva NC, Pappas JG, Bhatla T, Raetz EA, Macari M, Ginsburg HB, Hajdu CH.

Am J Surg Pathol. 2012 Jan;36(1):149-53. doi: 10.1097/PAS.0b013e31823d0560. Review.

PMID:
22173120
26.

Magnetization transfer contrast-prepared MR imaging of the liver: inability to distinguish healthy from cirrhotic liver.

Rosenkrantz AB, Storey P, Gilet AG, Niver BE, Babb JS, Hajdu CH, Lee VS.

Radiology. 2012 Jan;262(1):136-43. doi: 10.1148/radiol.11111043. Epub 2011 Nov 23.

PMID:
22114240
27.

Leiomyosarcoma of the splenic vein.

Gage MJ, Newman E, Maldonado TS, Hajdu CH.

J Vasc Surg. 2012 May;55(5):1485-7. doi: 10.1016/j.jvs.2011.09.053. Epub 2011 Nov 1.

28.

Adult polyglucosan body disease: a rare presentation with chronic liver disease and ground-glass hepatocellular inclusions.

Hajdu CH, Lefkowitch JH.

Semin Liver Dis. 2011 May;31(2):223-9. doi: 10.1055/s-0031-1276649. Epub 2011 May 2.

PMID:
21538287
29.

Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI?

Chandarana H, Robinson E, Hajdu CH, Drozhinin L, Babb JS, Taouli B.

AJR Am J Roentgenol. 2011 May;196(5):1083-9. doi: 10.2214/AJR.10.4720.

PMID:
21512074
30.

Imaging appearance of bulk fat within an oncocytic adrenocortical neoplasm, a rare and potentially malignant tumour.

Rosenkrantz AB, Do RK, Hajdu CH.

Br J Radiol. 2010 Oct;83(994):e204-7. doi: 10.1259/bjr/50022555. Review.

31.

Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ.

Do RK, Chandarana H, Felker E, Hajdu CH, Babb JS, Kim D, Taouli B.

AJR Am J Roentgenol. 2010 Sep;195(3):671-6. doi: 10.2214/AJR.09.3448. Erratum in: AJR Am J Roentgenol. 2010 Oct;195(4):1043. Chandanara, Hersh [corrected to Chandarana, Hersh].

PMID:
20729445
32.

Levels of elevated circulating endothelial cell decline after tumor resection in patients with pancreatic ductal adenocarcinoma.

Sabbaghian MS, Rothberger G, Alongi AP, Gagner JP, Goldberg JD, Rolnitzky L, Chiriboga L, Hajdu CH, Zagzag D, Basch R, Shamamian P.

Anticancer Res. 2010 Jul;30(7):2911-7.

PMID:
20683032
33.

Quantification of hepatic iron deposition in patients with liver disease: comparison of chemical shift imaging with single-echo T2*-weighted imaging.

Lim RP, Tuvia K, Hajdu CH, Losada M, Gupta R, Parikh T, Babb JS, Taouli B.

AJR Am J Roentgenol. 2010 May;194(5):1288-95. doi: 10.2214/AJR.09.3036.

PMID:
20410416
34.

Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction.

Kim S, Mannelli L, Hajdu CH, Babb JS, Clark TW, Hecht EM, Taouli B.

J Magn Reson Imaging. 2010 Feb;31(2):348-55. doi: 10.1002/jmri.22038.

PMID:
20099348
35.

Hepatic iron deposition in patients with liver disease: preliminary experience with breath-hold multiecho T2*-weighted sequence.

Chandarana H, Lim RP, Jensen JH, Hajdu CH, Losada M, Babb JS, Huffman S, Taouli B.

AJR Am J Roentgenol. 2009 Nov;193(5):1261-7. doi: 10.2214/AJR.08.1996.

PMID:
19843739
36.

Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.

Mannelli L, Kim S, Hajdu CH, Babb JS, Clark TW, Taouli B.

AJR Am J Roentgenol. 2009 Oct;193(4):1044-52. doi: 10.2214/AJR.08.1461.

PMID:
19770328
37.

Differentiating pancreatic cystic neoplasms from pancreatic pseudocysts at MR imaging: value of perceived internal debris.

Macari M, Finn ME, Bennett GL, Cho KC, Newman E, Hajdu CH, Babb JS.

Radiology. 2009 Apr;251(1):77-84. doi: 10.1148/radiol.2511081286.

PMID:
19332847
38.

Wilson disease and hepatocellular carcinoma.

Xu R, Hajdu CH.

Gastroenterol Hepatol (N Y). 2008 Jun;4(6):438-9. No abstract available.

39.
40.

Intrahepatic portal cavernoma as an indication for liver transplantation.

Hajdu CH, Murakami T, Diflo T, Taouli B, Laser J, Teperman L, Petrovic LM.

Liver Transpl. 2007 Sep;13(9):1312-6.

Supplemental Content

Loading ...
Support Center